Navigation Links
National Jewish Health researchers awarded $13 million to evaluate treatments for toxic gases
Date:10/13/2011

National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.

"The excitement about these studies is that they are designed to provide rescue treatments," said Carl White, MD, principal investigator of the grant.

The grant, part of the NIH's Countermeasures Against Chemical Threats Research Network (CounterACT), is for 5 years. The rescue agents to be given greatest study in these trials will include fibrinolytics ('clot busters'), anticoagulants, catalytic antioxidants, and flavonoids (specific herbal remedies). Researchers will evaluate models of damage to the lungs and airways and to skin.

"We have already found very encouraging preliminary data in which some of our agents can be effective even when given several hours after the toxic inhalation," said Dr. White. "This is important because real world conditions can cause minutes to hours of delay in getting to victims of such tragedies."

The work involves collaborations between two teams of investigators at National Jewish Health and one from the University of Colorado School of Pharmacy, as well as a collaborating center at the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD).

"The drugs we are testing work through several different mechanisms so that they may prevent or limit progressive damage to airways or skin, as well as prevent or clear blockage of airways," said Dr. White. "It is also exciting that some of the treatments we develop may also carry over to other difficult lung diseases of childhood and adults."

The initial focus of the research is on the acute injury to lungs and skin occurring in the first 24-48 hours of exposure. As the studies progress over the next several years, researchers hope to evaluate the ability of our relatively early interventions to prevent lung fibrosis and bronchiolitis obliterans that can result from such exposures.


'/>"/>
Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Related medicine news :

1. NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010
2. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
3. National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal
4. Howard Dean to Speak at the 2010 DTC National Conference
5. International Diabetes Federation awards $2 million to 9 global diabetes research projects
6. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
7. U.S. National Guard Connects Nationwide with Desktop Alert's Command and Control Mass Notification Systems and Common Alerting Protocol (CAP)
8. H1N1 international symposium to be hosted by Emory-UGA Influenza Center
9. The Alliance for a Healthier Generation Names Celtics Captain Paul Pierce National Athlete Spokesperson in the Fight Against Childhood Obesity
10. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
11. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology: